Clinical trials
Completed Observational Colorectal Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
639 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 4 |
| 2001 | 3 |
| 2002 | 4 |
| 2003 | 11 |
| 2004 | 7 |
| 2005 | 9 |
| 2006 | 23 |
| 2007 | 20 |
| 2008 | 20 |
| 2009 | 25 |
| 2010 | 31 |
| 2011 | 29 |
| 2012 | 41 |
| 2013 | 24 |
| 2014 | 33 |
| 2015 | 33 |
| 2016 | 29 |
| 2017 | 30 |
| 2018 | 38 |
| 2019 | 31 |
| 2020 | 37 |
| 2021 | 45 |
| 2022 | 40 |
| 2023 | 28 |
| 2024 | 19 |
| 2025 | 8 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 639 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 25 |
| Bayer | 16 |
| Exact Sciences Corporation | 13 |
| M.D. Anderson Cancer Center | 13 |
| Memorial Sloan Kettering Cancer Center | 13 |
| Alliance for Clinical Trials in Oncology | 10 |
| Jagiellonian University | 7 |
| Amgen | 6 |
| City of Hope Medical Center | 5 |
| Fudan University | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colorectal Neoplasms | 639 |
| Colonic Neoplasms | 87 |
| Breast Neoplasms | 51 |
| Rectal Neoplasms | 46 |
| Lung Neoplasms | 39 |
| Neoplasms | 36 |
| Pancreatic Neoplasms | 33 |
| Prostatic Neoplasms | 26 |
| Stomach Neoplasms | 26 |
| Neoplasm Metastasis | 22 |
Trials
Showing 1 to 25 of 639. Each trial links to its page on Pharma Observatory.
539 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.